Suzuki, Miki
Numata, Keiji
Funding for this research was provided by:
MEXT | Japan Science and Technology Agency
Article History
Received: 27 June 2025
Revised: 6 November 2025
Accepted: 24 February 2026
First Online: 23 March 2026
Competing interests
: Keiji Numata is the CTO of Symbiobe Inc., a start-up company affiliated with Kyoto University.
: All genetic recombination experiments were performed in accordance with the guidelines and regulations of Kyoto University and were approved by the Kyoto University Recombinant DNA Experiment Safety Committee (Approval no. 250049).